Omega Therapeutics Inc. (OMGA)
0.61
0.01 (2.18%)
At close: Jan 15, 2025, 10:37 AM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Revenue | 3.09M | 2.07M | 144.00K | n/a | n/a |
| Cost of Revenue | 65.87M | 5.19M | 1.39M | 1.15M | 794.00K |
| Gross Profit | -62.77M | -3.12M | -1.24M | -1.15M | -794.00K |
| Operating Income | -100.26M | -102.77M | -66.03M | -28.64M | -17.34M |
| Interest Income | 2.81M | 222.00K | 910.00K | 777.00K | 595.00K |
| Pretax Income | -97.43M | -102.70M | -68.28M | -29.45M | -17.95M |
| Net Income | -97.43M | -102.64M | -69.16M | -30.20M | -18.53M |
| Selling & General & Admin | 26.19M | 21.82M | 16.60M | 6.24M | 4.23M |
| Research & Development | 77.17M | 80.00M | 47.87M | 21.06M | 11.93M |
| Other Expenses | n/a | 3.02M | 1.71M | 1.35M | 1.18M |
| Operating Expenses | 103.36M | 104.84M | 66.18M | 28.64M | 17.34M |
| Interest Expense | n/a | 222.00K | 910.00K | 777.00K | 595.00K |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 103.36M | 104.84M | 66.18M | 28.64M | 17.34M |
| Income Tax | n/a | -65.00K | 882.00K | 752.00K | 584.00K |
| Shares Outstanding (Basic) | 54.01M | 47.88M | 47.79M | 47.84M | 47.84M |
| Shares Outstanding (Diluted) | 54.01M | 47.88M | 47.79M | 47.84M | 47.84M |
| EPS (Basic) | -1.8 | -2.14 | -1.45 | -0.63 | -0.39 |
| EPS (Diluted) | -1.8 | -2.14 | -1.45 | -0.63 | -0.39 |
| EBITDA | -93.49M | -97.58M | -64.64M | -27.50M | -16.55M |
| Depreciation & Amortization | 6.77M | 5.19M | 1.39M | 1.15M | 794.00K |